Literature DB >> 12856229

Clinical and laboratory findings on the first imported case of Murray Valley encephalitis in Europe.

August Stich1, Stephan Günther, Christian Drosten, Petra Emmerich, Dominic E Dwyer, Linda Hueston, Wolfgang Hetzel, Armin Kirschner, Klaus Fleischer.   

Abstract

Murray Valley encephalitis (MVE) is an important mosquitoborne flavivirus infection endemic to Australia and Papua New Guinea. We report the first imported case of MVE in Europe. A 23-year-old tourist developed severe encephalitis after having returned to Germany from a long-term trip across the Australian continent. The diagnosis was suspected on the basis of clinical findings and the patient's travel history and was confirmed by serological findings. The patient made a prolonged but complete recovery. Our case coincides with a recently reported spread of MVE virus in Australia. This emphasizes the need for continuous surveillance in areas of endemicity and appropriate protection when traveling through regions in which the MVE virus is endemic.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856229     DOI: 10.1086/375068

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Clinical and radiological predictors of outcome for Murray Valley encephalitis.

Authors:  David J Speers; James Flexman; Christopher C Blyth; Nirooshan Rooban; Edward Raby; Ganesh Ramaseshan; Susan Benson; David W Smith
Journal:  Am J Trop Med Hyg       Date:  2013-01-07       Impact factor: 2.345

2.  Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.

Authors:  Mario Lobigs; Maximilian Larena; Mohammed Alsharifi; Eva Lee; Megan Pavy
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

3.  Fatal Infection with Murray Valley Encephalitis Virus Imported from Australia to Canada, 2011.

Authors:  Daniel J Niven; Kevin Afra; Mircea Iftinca; Raymond Tellier; Kevin Fonseca; Andreas Kramer; David Safronetz; Kimberly Holloway; Michael Drebot; Andrew S Johnson
Journal:  Emerg Infect Dis       Date:  2017-02       Impact factor: 6.883

4.  Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans.

Authors:  D Ludolfs; M Niedrig; J T Paweska; H Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.